On November 4, 2019 Vivoryon Therapeutics AG (Euronext Amsterdam: VVY), reported that the company is scheduled to attend and present at upcoming conferences in November (Press release, Vivoryon Therapeutics, NOV 4, 2019, View Source [SID1234550200]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(1) BIO Europe

November 11-13, 2019; Hamburg Messe, Hamburg, Germany

Dr. Ulrich Dauer, CEO, and Dr. Michael Schaeffer, CBO, to host meetings
Dr. Dauer to present on Monday, November 11, 2019; at 3:30pm CET, in Hall B1, Room 6 on Level 1

(2) Deutsches Eigenkapitalforum

November 25-27, 2019; Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt, Germany

Dr. Ulrich Dauer, CEO, to host meetings and present on Monday November 25, 2019; at 3:00pm CET in Room Oslo